Home-based Exercise in Chronic Kidney Disease (HBCKD-BCN)

February 26, 2019 updated by: Eva Segura Ortí, Cardenal Herrera University

Effects of Home-based Exercise in Advanced Chronic Kidney Disease and End-stage Renal Disease

A home-based exercise program will be implemented in three different groups of participants: advanced chronic kidney disease, end-stage renal disease in substitutive treatment hemodialysis or peritoneal dialysis. Participants will be evaluated before the program, after 3 months and after 6 months from the starting of the program. During the first 3 months the researcher will phone them weekly to reinforce the exercise habit, and during the last three months, there will be no reinforcement. Assessment will include strength, functional capacity, health-related quality of life and depressive symptoms.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Three groups of participants (advanced chronic disease not yet in substitutive treatment, end-stage renal disease patients in hemodialysis and end-stage renal disease patients in peritoneal dialysis) will enter the study. The intervention will consist of a home-based exercise program. They will be provided with a booklet and the researcher will explain personally each of the exercises to the participants. Progression will be encouraged so that the participants should find the sessions 'somewhat hard' according to the rate of perceived exertion. Reinforcement will be high during the first 3 months (weekly phone calls, visits to the nephrology department) and none during the last 3 months. Assessment will be undertaken at three-time points: baseline, after 3 months of high reinforcement and after 3 more months of no reinforcement at all.

Assessment will include strength, functional capacity, health-related quality of life, cognitive state and depressive symptoms.

The aim of the study is to assess the effectiveness of home-based exercise to improve strength, physical function, health-related quality of life, cognitive state and depressive symptoms in advanced chronic kidney disease and end-stage renal disease (hemodialysis and peritoneal dialysis). We also aim at describing all these variables in the three different groups of patients. Adherence and satisfaction with the exercise program will be recorded at the end of the study.

Additionally, interobserver reliability will be calculated, so as reliability intraobserver in different measurement conditions (dialysis vs non-dialysis days).

Study Type

Interventional

Enrollment (Actual)

57

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Barcelona
      • Terrassa, Barcelona, Spain, 08227
        • Hospital de Terrassa

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • At least 3 months in hemodialysis treatment
  • Clinically stable

Exclusion Criteria:

  • Recent cardiac events (less than 3 months)
  • Unable to exercise

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Home-based exercise
Home-based intervention in the advanced chronic kidney disease group, hemodialysis or peritoneal dialysis group
A booklet with detailed information will be provided, and the exercises will be previously reviewed with every patient by the researcher. Participants will be encouraged to perform at least 3 sessions per week and monitor their heart rate. They will be instructed that the exercises should be perceived as 'somewhat hard' from a rate of perceived exertion. Adaptations to increase the intensity of the exercises will be provided so that participants can progress in exercise intensity

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline sit to stand 10 test at 12 and 24 weeks
Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
Sit to stand to sit test 10, time to perform 10 repetitions
Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline Six-minute walking test at 12 and 24 weeks
Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
Distance covered in 6 minutes
Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
Change from baseline STS-60 at 12 and 24 weeks
Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
Sit to stand to sit test 60, number of repetitions performed during 60 seconds
Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
Change from baseline OLHR at 12 and 24 weeks
Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
One leg heel rise test, number of repetitions of heel rise to measure triceps strength
Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
Change from baseline Handgrip strength (dynamometry) at 12 and 24 weeks
Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
Handgrip strength measured through a dynamometer
Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
Change from baseline SPPB at 12 and 24 weeks
Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
Short physical performance battery, a combination of walking speed, STS-5 and balance
Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
Change from baseline OLST at 12 and 24 weeks
Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
One-leg stand test, time to keep the balance in one leg
Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
Change from baseline TUG at 12 and 24 weeks
Time Frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
Timed up and go test, time to stand up from a chair, walk 3m, turn around and sit back again
Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
Change from baseline Albumin at 12 and 24 weeks
Time Frame: Baseline,12 weeks, 24 weeks
Serum albumin in blood for dialysis patients
Baseline,12 weeks, 24 weeks
Change from baseline Health-related quality of life measured through the Euro quality of life questionnaire, 5 dimensions, at 12 and 24 weeks
Time Frame: Baseline,12 weeks, 24 weeks
Euroquol 5D questionnaire, scale 0 (worst health) to 100 (best health). 5 Dimensions include mobility, personal care, activities of daily living, pain, and anxiety/depression
Baseline,12 weeks, 24 weeks
Change from baseline Beck depression inventory at 12 and 24 weeks
Time Frame: Baseline,12 weeks, 24 weeks
Questionnaire to measure depressive symptoms. Range from 0 (normal) to 63 (worst depression)
Baseline,12 weeks, 24 weeks
Change from baseline Human activity profile at 12 and 24 weeks Human activity profile
Time Frame: Baseline,12 weeks, 24 weeks
Questionnaire to measure physical activity. Higher score represents higher activity. Measures of average and maximal activity scores are reported. Average activity scores bellow 53 are considered impaired; between 53 and 74 are considered moderately active and above 74 are considered active.
Baseline,12 weeks, 24 weeks
Change from baseline Physical Activity Scale for the elderly at 12 and 24 weeks
Time Frame: Baseline,12 weeks, 24 weeks
Questionnaire to measure physical activity. Higher scores represent higher activity.
Baseline,12 weeks, 24 weeks
Adherence
Time Frame: 12 weeks, 24 weeks
Sessions performed/offered x 100
12 weeks, 24 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 1, 2018

Primary Completion (ACTUAL)

January 31, 2019

Study Completion (ACTUAL)

February 14, 2019

Study Registration Dates

First Submitted

July 23, 2018

First Submitted That Met QC Criteria

August 3, 2018

First Posted (ACTUAL)

August 8, 2018

Study Record Updates

Last Update Posted (ACTUAL)

February 27, 2019

Last Update Submitted That Met QC Criteria

February 26, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Kidney Disease

Clinical Trials on Home-based exercise

3
Subscribe